Beaune P - Search Results

1

Pharmacokinetic interaction between corticosteroids and tacrolimus after renal transplantation.

Anglicheau D, Flamant M, Schlageter MH, Martinez F, Cassinat B, Beaune P, Legendre C, Thervet E. Anglicheau D, et al. Among authors: beaune p. Nephrol Dial Transplant. 2003 Nov;18(11):2409-14. doi: 10.1093/ndt/gfg381. Nephrol Dial Transplant. 2003. PMID: 14551375

2

Association of the multidrug resistance-1 gene single-nucleotide polymorphisms with the tacrolimus dose requirements in renal transplant recipients.

Anglicheau D, Verstuyft C, Laurent-Puig P, Becquemont L, Schlageter MH, Cassinat B, Beaune P, Legendre C, Thervet E. Anglicheau D, et al. Among authors: beaune p. J Am Soc Nephrol. 2003 Jul;14(7):1889-96. doi: 10.1097/01.asn.0000073901.94759.36. J Am Soc Nephrol. 2003. PMID: 12819250

3

Impact of cytochrome p450 3A5 genetic polymorphism on tacrolimus doses and concentration-to-dose ratio in renal transplant recipients.

Thervet E, Anglicheau D, King B, Schlageter MH, Cassinat B, Beaune P, Legendre C, Daly AK. Thervet E, et al. Among authors: beaune p. Transplantation. 2003 Oct 27;76(8):1233-5. doi: 10.1097/01.TP.0000090753.99170.89. Transplantation. 2003. PMID: 14578760

4

CYP3A5 and MDR1 genetic polymorphisms and cyclosporine pharmacokinetics after renal transplantation.

Anglicheau D, Thervet E, Etienne I, Hurault De Ligny B, Le Meur Y, Touchard G, Büchler M, Laurent-Puig P, Tregouet D, Beaune P, Daly A, Legendre C, Marquet P. Anglicheau D, et al. Among authors: beaune p. Clin Pharmacol Ther. 2004 May;75(5):422-33. doi: 10.1016/j.clpt.2004.01.009. Clin Pharmacol Ther. 2004. PMID: 15116055

5

Consequences of genetic polymorphisms for sirolimus requirements after renal transplant in patients on primary sirolimus therapy.

Anglicheau D, Le Corre D, Lechaton S, Laurent-Puig P, Kreis H, Beaune P, Legendre C, Thervet E. Anglicheau D, et al. Among authors: beaune p. Am J Transplant. 2005 Mar;5(3):595-603. doi: 10.1111/j.1600-6143.2005.00745.x. Am J Transplant. 2005. PMID: 15707415 Free article.

6

Role of pharmacogenetics of immunosuppressive drugs in organ transplantation.

Thervet E, Anglicheau D, Legendre C, Beaune P. Thervet E, et al. Among authors: beaune p. Ther Drug Monit. 2008 Apr;30(2):143-50. doi: 10.1097/FTD.0b013e31816babef. Ther Drug Monit. 2008. PMID: 18367973 Review.

7

Long-term results of TPMT activity monitoring in azathioprine-treated renal allograft recipients.

Thervet E, Anglicheau D, Toledano N, Houllier AM, Noel LH, Kreis H, Beaune P, Legendre C. Thervet E, et al. Among authors: beaune p. J Am Soc Nephrol. 2001 Jan;12(1):170-176. doi: 10.1681/ASN.V121170. J Am Soc Nephrol. 2001. PMID: 11134264

8

Cytochrome P450 3A polymorphisms and immunosuppressive drugs.

Thervet E, Legendre C, Beaune P, Anglicheau D. Thervet E, et al. Among authors: beaune p. Pharmacogenomics. 2005 Jan;6(1):37-47. doi: 10.1517/14622416.6.1.37. Pharmacogenomics. 2005. PMID: 15723604 Review.

9

[mTOR inhibitors: pleiotropic antiproliferative drugs].

Pallet N, Beaune P, Thervet E, Legendre C, Anglicheau D. Pallet N, et al. Among authors: beaune p. Med Sci (Paris). 2006 Nov;22(11):947-52. doi: 10.1051/medsci/20062211947. Med Sci (Paris). 2006. PMID: 17101096 Free article. Review. French.

10

Cytochrome P450 3A polymorphisms and immunosuppressive drugs: an update.

Anglicheau D, Legendre C, Beaune P, Thervet E. Anglicheau D, et al. Among authors: beaune p. Pharmacogenomics. 2007 Jul;8(7):835-49. doi: 10.2217/14622416.8.7.835. Pharmacogenomics. 2007. PMID: 18240909 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

330 results

Search Page

Filters